Behavioral Health Medication Management Resources
Psychotherapeutic Medication Legislation
Pursuant to statute F.S. 409.912(51) The Agency may not pay for a psychotropic medication prescribed for a child in the Medicaid program without the express and informed consent of the child's parent or legal guardian. The physician shall document the consent in the child's medical record and provide the pharmacy with a signed attestation of this documentation with the prescription.
- Florida Medicaid Consent Form [140KB]
- Department of Children and Family Services (DCF) Consent Form CF 1630 [282KB]
- Department of Children and Family Services (DCF) Consent Form CF FSP 5339, (only page 8 required) [514KB]
- Department of Juvenile Justice Consent Form HS 006, (only page 3 required) [92KB]
- Clinical Guidelines for the Use of Behavioral Health Medications in Children and Adolescents
- Clinical Guidelines for the Use of Behavioral Health Medications in Adults
- Evidence Based Medication Dosing Tables
- High Dose Antipsychotic Table for Children and Adolescents
- Videos and Presentations by National and International Experts in the Field of Psychiatry
This valuable new service is administered by the Florida Medicaid Drug Therapy Management Program for Behavioral Health located at the Florida Mental Health Institute (FMHI) at the University of South Florida. The call line serves prescribing clinicians who have questions about the medical care of children and adolescents with psychiatric needs. Consultations are limited to discussions concerning medication. Additional information including registration requirements, program details and hotline phone numbers are available by clicking on the subject line above.
Comments concerning the program from a pediatrician serving Medicaid recipients in the Gainesville area:
- Access has been very easy and the response times have been amazing.
- The advice has been completely practical, including references for screening tools and recommendations for medications.
- When appointments have been advised or requested, the preliminary contact has helped to expedite care.
- In the face of the extreme shortage of child psychiatrists, this has been an invaluable service.
- Buprenorphine Physician and Treatment Locator
- Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction
- Medication Treatment Improvement Protocols for Substance Abuse Disorders
- SAMHSA Sponsored Buprenorphine Physician Clinical Support System (PCSS)
Adverse Event Reporting
Consumers and health professionals are encouraged to report problems (adverse reactions) with behavioral health medications to the Food and Drug Administration (FDA). Please click on the link below to access the FDA Safety page and report a problem.